ArticleCancer immunology, immunotherapy : CII2019

Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine.

Caterina Lapenta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.